Cookson Peirce & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,000
| Closed | -$208K | – | 308 |
|
|
2025
Q1 | $208K | Buy |
+3,000
| New | +$208K | 0.01% | 260 |
|
|
2024
Q4 | – | Sell |
-3,036
| Closed | -$361K | – | 293 |
|
|
2024
Q3 | $361K | Sell |
3,036
-34
| -1% | -$4.05K | 0.02% | 218 |
|
|
2024
Q2 | $438K | Sell |
3,070
-100
| -3% | -$14.3K | 0.02% | 180 |
|
|
2024
Q1 | $407K | Hold |
3,170
| – | – | 0.02% | 177 |
|
|
2023
Q4 | $328K | Hold |
3,170
| – | – | 0.02% | 174 |
|
|
2023
Q3 | $288K | Hold |
3,170
| – | – | 0.02% | 181 |
|
|
2023
Q2 | $257K | Buy |
+3,170
| New | +$257K | 0.02% | 185 |
|